This site is intended for US Consumers.
For postmenopausal women with HR+ breast cancer
Image of lady
Consulting
With My
Pharmacist
Strikethrough Pharmacist Students
The Benefits of ARIMIDEX Patient Direct:
$2 A Day
  • Automatic Refills Delivered to Your Door
  • Refill Reminders
  • Free Shipping
  • Pharmacist Support
Take Control
With AMIRIDEX Patient Direct

Take Control With ARIMIDEX Patient Direct

If you and your doctor determine ARIMIDEX is right for you, all you need to enroll in the ARIMIDEX Patient Direct program – including if you are a Medicaid or Medicare Part D recipient* – is a valid prescription for ARIMIDEX or generic anastrozole. Through ARIMIDEX Patient Direct, ARIMIDEX tablets are available for $60 (30-day supply) or $180 (90-day supply) – only $2 a day. You’ll also enjoy free home delivery, automatic refills, refill reminders, and the opportunity to check in with a pharmacist if needed.

Benefits of ARIMIDEX Patient Direct:

  • Brand name ARIMIDEX
  • Just $2 a day
  • Free Shipping
  • Auto-Refills
  • Refill Reminders
  • Pharmacist Support

Enrollment in ARIMIDEX Patient Direct is easy. Simply complete the online form and send your prescription to Eagle Pharmacy. Once you’ve enrolled in the program and sent your prescription to Eagle Pharmacy, you will receive your order in 7-10 days.

*Coverage for Medicaid and Medicare

This offer is valid for prescriptions purchased under Medicaid and similar state or federally funded medical assistance programs. Medicare Part D prescription orders will be processed without the use of insurance and cannot be applied to true out-of-pocket (TrOOP) costs. Prescription required.

Still have questions?

Find answers on our ARIMIDEX Patient Direct FAQ page

Terms and Conditions

Patients must have a valid prescription for ARIMIDEX® (anastrozole) tablets.

By enrolling, the patient elects to receive the branded product and acknowledges that no generic substitution will be offered (if applicable). Should the patient wish to receive a generic product in the future, the patient will need to call 1-855-250-2483 to opt out of this program.

ARIMIDEX: Patients will pay cash price of $60 for 30-day supply (30 tablets) or $180 for 90-day supply (90 tablets) of ARIMIDEX. All orders are processed without the use of insurance and cannot be applied to deductibles. Taxes may apply.

ANI Pharmaceuticals, Inc. retains the right to rescind, revoke, or amend this offer at any time without notice.

Important Safety Information About ARIMIDEX

  • Prescription ARIMIDEX is only for postmenopausal women. ARIMIDEX should not be taken if you are pregnant because it may harm your unborn child. Do not take ARIMIDEX if you are allergic to any of its ingredients
  • Based on information from a study in patients with early breast cancer, women with a history of blockages in heart arteries (ischemic heart disease) who take ARIMIDEX may have a slight increase in this type of heart disease compared to similar patients who take tamoxifen
  • ARIMIDEX can cause bone softening/weakening (osteoporosis) increasing the chance of fractures. In a clinical study in early breast cancer, there were more fractures (including fractures of the spine, hip, and wrist) with ARIMIDEX (10%) than with tamoxifen (7%)
  • In a clinical study in early breast cancer, some patients taking ARIMIDEX had an increase in cholesterol. Skin reactions, allergic reactions, and changes in blood tests of liver function have also been reported
  • In the early breast cancer clinical trial, the most common side effects seen with ARIMIDEX include hot flashes, joint symptoms (including arthritis and arthralgia), weakness, mood changes, pain, back pain, sore throat, nausea and vomiting, rash, depression, high blood pressure, osteoporosis, fractures, swelling of arms/legs, insomnia, and headache
  • In advanced breast cancer trials, the most common side effects seen with ARIMIDEX versus tamoxifen include hot flashes, nausea, decreased energy and weakness, pain, back pain, headache, bone pain, increased cough, shortness of breath, sore throat, and swelling of arms and legs. Joint pain/stiffness has been reported in association with the use of ARIMIDEX
  • ARIMIDEX should not be taken with tamoxifen or estrogen-containing therapies

Approved Uses for ARIMIDEX

ARIMIDEX is approved for adjuvant treatment (treatment following surgery with or without radiation) of postmenopausal women with hormone receptor-positive early breast cancer.

ARIMIDEX is approved for the initial treatment of postmenopausal women with hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer and for the treatment of postmenopausal women with advanced breast cancer that has progressed following treatment with tamoxifen. Patients with hormone receptor-negative disease and patients who did not previously respond to tamoxifen therapy rarely responded to ARIMIDEX.

For more information, see your doctor. Please see full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

US FlagThis site is intended for US consumers only.

The information on this Web site should not take the place of talking with your doctor or health care professional. If you have any questions about your condition, or if you would like more information about ARIMIDEX, talk to your doctor or pharmacist. Only you and your health care professional can decide if ARIMIDEX is right for you.